AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Receptors, Progesterone

Showing 1 to 10 of 26 articles

Clear Filters

Advances in research on receptor heterogeneity in breast cancer liver metastasis.

Bioscience trends
Breast cancer liver metastasis (BCLM) presents a critical challenge in breast cancer treatment and has substantial epidemiological and clinical significance. Receptor status is pivotal in managing both primary breast cancer and its liver metastases. ...

Histopathologic Differential Diagnosis and Estrogen Receptor/Progesterone Receptor Immunohistochemical Evaluation of Breast Carcinoma Using a Deep Learning-Based Artificial Intelligence Architecture.

The American journal of pathology
In breast carcinoma, invasive ductal carcinoma (IDC) is the most common histopathologic subtype, and ductal carcinoma in situ (DCIS) is a precursor of IDC. These two often occur concomitantly. The immunohistochemical staining of estrogen receptor (ER...

Development and Validation of a Machine Learning Radiomics Model based on Multiparametric MRI for Predicting Progesterone Receptor Expression in Meningioma: A Multicenter Study.

Academic radiology
RATIONALE AND OBJECTIVES: This study aimed to develop and validate a machine learning-based prediction model for preoperatively predicting progesterone receptor (PR) expression in meningioma patients using multiparametric magnetic resonance imaging (...

Screening of BindingDB database ligands against EGFR, HER2, Estrogen, Progesterone and NF-κB receptors based on machine learning and molecular docking.

Computers in biology and medicine
Breast cancer, the second most prevalent cancer among women worldwide, necessitates the exploration of novel therapeutic approaches. To target the four subgroups of breast cancer "hormone receptor-positive and HER2-negative, hormone receptor-positive...

Multimodal integration using a machine learning approach facilitates risk stratification in HR+/HER2- breast cancer.

Cell reports. Medicine
Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer is the most common type of breast cancer, with continuous recurrence remaining an important clinical issue. Current relapse predictive models in H...

Insights into AI advances in immunohistochemistry for effective breast cancer treatment: a literature review of ER, PR, and HER2 scoring.

Current medical research and opinion
Breast cancer is a significant health challenge, with accurate and timely diagnosis being critical to effective treatment. Immunohistochemistry (IHC) staining is a widely used technique for the evaluation of breast cancer markers, but manual scoring ...

An assessment of breast cancer HER2, ER, and PR expressions based on mammography using deep learning with convolutional neural networks.

Scientific reports
Mammography is the recommended imaging modality for breast cancer screening. Expressions of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR) are critical to the development of therapeutic strateg...

Toward Accurate Deep Learning-Based Prediction of Ki67, ER, PR, and HER2 Status From H&E-Stained Breast Cancer Images.

Applied immunohistochemistry & molecular morphology : AIMM
Despite improvements in machine learning algorithms applied to digital pathology, only moderate accuracy, to predict molecular information from histology alone, has been achieved so far. One of the obstacles is the lack of large data sets to properly...